| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |